000 01222 a2200325 4500
005 20250515164234.0
264 0 _c20091117
008 200911s 0 0 eng d
022 _a1872-6240
024 7 _a10.1016/j.brainres.2009.03.037
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRavindran, Lakshmi N
245 0 0 _aPharmacotherapy of PTSD: premises, principles, and priorities.
_h[electronic resource]
260 _bBrain research
_cOct 2009
300 _a24-39 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenergic Antagonists
_xtherapeutic use
650 0 4 _aAnticonvulsants
_xtherapeutic use
650 0 4 _aAntidepressive Agents
_xtherapeutic use
650 0 4 _aGlutamic Acid
_xmetabolism
650 0 4 _aHumans
650 0 4 _aHypothalamo-Hypophyseal System
_xphysiopathology
650 0 4 _aNorepinephrine
_xmetabolism
650 0 4 _aPituitary-Adrenal System
_xphysiopathology
650 0 4 _aSerotonin
_xmetabolism
650 0 4 _aStress Disorders, Post-Traumatic
_xdrug therapy
700 1 _aStein, Murray B
773 0 _tBrain research
_gvol. 1293
_gp. 24-39
856 4 0 _uhttps://doi.org/10.1016/j.brainres.2009.03.037
_zAvailable from publisher's website
999 _c18768394
_d18768394